progen pharmaceuticals ltd
(PGL:Australian Stock Exchange Ltd)
Transactions by PROGEN PHARMACEUTICALS LTD (PGL) in the last 6 months
TBG Inc. signed a binding term sheet to acquire Progen Pharmaceuticals Limited (ASX:PGL) from Medigen Biotechnology Corp. (GTSM:3176) and other shareholders in a reverse merger transaction on May 1, 2015. Progen Pharmaceuticals will issue approximately 101.72 million new shares in the deal, being 64.8% of the enlarged capital. The proposed acquisition is subject to due diligence, regulatory approvals, Progen Pharmaceuticals shareholder approval and successful capital ...
|No competitor information is available for PGL.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|